We have confirmed progression in our patient’s CLL.
There is no evidence of haemolysis.
He has a pmh of HTN, diabetes, mild copd and osteoarthritis which limits his mobility. He has an ecog of 2 (was 1 prior to the progression of his cll and resultant fatigue).
He has been started on chloramucil and obinituzumab however during the first obinutuzumab infusion he develops pyexia, and rigors.
- What do you think is happening?
- What would you do?
Join us on Twitter @TeamHaem and let us know what your thoughts are, what questions you have and what you want to do as we see this case evolve over the next week. Remember to use #teamhaem on all your posts to help us follow the case! Please note – all cases on TeamHaem are entirely fictional to protect patient confidentiality. TeamHaem are not a position of authority. It is an educational platform to allow discussion and learning.